Evidence map›Paper›PMID 42362993›Full record

ArticleEye (London, England)2026

Eyes of Africa: The Genetics of Blindness. Baseline characteristics, ocular features, and associations with glaucoma in continental Africans.

Adeyinka Ashaye, Olusola Olawoye, Kelsey V Stuart, Tarela Sarimiye, Chimdi Chuka-Okosa, Nkiru Kizor-Akaraiwe, Ugbede Idakwo, Naa Naamuah Tagoe, Kwesi Nyan Amissah-Arthur, Kuburat O Adenrele and 38 more

Abstract readMulticenter Study
In one paragraph

Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Adeyinka Ashaye *Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Olusola Olawoye *Department of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria. solaolawoye@yahoo.com.ORCID http://orcid.org/0000-0003-2357-8924
Kelsey V Stuart *NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.ORCID http://orcid.org/0000-0001-7353-8774
Tarela SarimiyeDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Chimdi Chuka-OkosaDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Nkiru Kizor-AkaraiweDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Ugbede IdakwoECWA Eye Hospital, Kano, Nigeria.ORCID http://orcid.org/0000-0001-9573-483X
Naa Naamuah TagoeLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwesi Nyan Amissah-ArthurLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.ORCID http://orcid.org/0000-0003-2018-2043
Kuburat O AdenreleAncilla Catholic Hospital Eye Centre, Lagos, Nigeria.
Chinedu Anthony OkekeDepartment of Ophthalmology, Nigerian Navy Reference Hospital, Ojo, Nigeria.
Akinyemi O AdedejiDepartment of Ophthalmology, Federal Medical Centre, Asaba, Nigeria.
Aderonke BaiyerojuDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.ORCID http://orcid.org/0000-0002-6121-4796
Onoja AkpaDepartment of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria.
Chimdia OgbonnayaAlex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria.
Oluwole MajekodunmiDepartment of Ophthalmology, University College Hospital, Ibadan, Nigeria.
Chinwe OtegbuluDepartment of Ophthalmology, Federal Medical Centre, Asaba, Nigeria.
Nkechi UcheDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Bernice AdegbehingbeDepartment of Ophthalmology, Obafemi Awolowo University/Teaching Hospitals Complex, Ile-Ife, Nigeria.
Adeola OnakoyaLagos University Teaching Hospital Idi Araba/College of Medicine University of Lagos, Lagos, Nigeria.
Oyetunde E OyedepoDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Oluwatobi J HussainDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Bola AdekoyaDepartment of Ophthalmology, Lagos State University Teaching Hospital, Ikeja GRA, Lagos, Nigeria.
Bolajoko Abidemi AdewaraDepartment of Ophthalmology, Obafemi Awolowo University/Teaching Hospitals Complex, Ile-Ife, Nigeria.ORCID http://orcid.org/0000-0002-1127-5638
Joseph Matiya MsosaThe Eyes for Africa Child Legacy Hospital, Lilongwe, Malawi.
Akosua Badu Mensa-BonsuLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwaku Oppong KwartengLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Yakubu Seidu AdamLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Kwame Okyere OseiLions International Eye Centre, Korle Bu Teaching Hospital, Accra, Ghana.
Edem LodohGreater Accra Regional Hospital, Accra, Ghana.
Benjamin AbaidooOphthalmology Unit, Department of Surgery, University of Ghana Medical School, Accra, Ghana.
Raymond ToseafaCocoa Clinic Eye Centre, Accra, Ghana.
Suhanyah OkekeDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Obinna ShiweobiDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Adaora OkudoDepartment of Surgery, Nile University of Nigeria, Abuja, Nigeria.
Chukwu OkoDepartment of Ophthalmology, College of Medicine, Enugu State University of Technology, Enugu, Nigeria.
Kayode FowobajeDepartment of Epidemiology and Medical Statistics, University of Ibadan, Ibadan, Nigeria.ORCID http://orcid.org/0000-0002-3995-160X
Benedict Gboyega AjayiEleta Eye Institute, Ibadan, Nigeria.
Adeyinka FalusiTrustee - Sickle Cell Hope Alive Foundation (SCHAF), Ibadan, Nigeria.
Ifeyinwa ObianwuDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Caroline AdeotiDepartment of Ophthalmology, Osun State University Teaching Hospital Osogbo, Osogbo, Nigeria.
Ugochukwu AnumuduDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Oluchi NnaegbunamDepartment of Ophthalmology, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Nigeria.
Adedapo AdejuwonDepartment of Ophthalmology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Nathan CongdonCentre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.ORCID http://orcid.org/0000-0001-9866-3416
Michael A HauserDepartment of Ophthalmology, Duke University, NC, USA.
Anthony P KhawajaNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.ORCID http://orcid.org/0000-0001-6802-8585
Tony RealiniDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceGlaucoma is the leading cause of irreversible blindness worldwide, with disproportionately high prevalence and severity in Africans.

objectiveTo characterise the baseline phenotypic findings and glaucoma-related ocular features of participants with primary open-angle glaucoma (POAG, cases) and non-glaucoma controls and to report sociodemographic and medical associations of POAG in the cohort.

designMulticentre, cross-sectional study.

participants9418 adults (5189 POAG cases; 4229 controls) recruited from 16 centres in Nigeria, Ghana and Malawi.

methodsStandardised demographic, medical and ophthalmic data were collected, including visual acuity, intraocular pressure (IOP), optic disc evaluation, visual fields and central corneal thickness.

main outcome measuresGlaucoma severity, visual impairment (VI) and sociodemographic/medical associations of POAG.

resultsCompared to controls, cases were older (mean age 63.9 years vs 61.4 years, P < 0.001) and more likely to be male (57.4% vs 45.2%, P < 0.001). Three-quarters of cases (76.8%) were classified as having severe glaucoma in at least one eye at recruitment, with a third (34.4%) suffering severe VI or blindness. The leading causes of VI in controls were cataract (65.0%) and uncorrected refractive error (13.8%). POAG was significantly associated with older age, male sex, higher level of education, unemployment, history of alcohol consumption, African trypanosomiasis, higher maximum IOP and a positive family history of glaucoma.

conclusionThere is a significant glaucoma disease burden in sub-Saharan Africa. Further analyses of the cohort will identify genetic determinants of these clinical findings and reinforce the urgent need for public health interventions in sub-Saharan Africa.

Indexed as

BlindnessGlaucoma, Open-AngleSub-Saharan African PeopleAdultAgedCross-Sectional StudiesFemaleGhanaHumansIntraocular PressureMalawiMaleMiddle AgedNigeriaPrevalenceVisual Acuity

Identifiers

PMID42362993
PMCPMC13538593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.